Global Predictive Genetic Testing And Consumer & Wellness Genomics Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Predictive Genetic Testing And Consumer & Wellness Genomics Market Research Report 2024
Predictive genetic testing is relatively new but rapidly emerging arena in public health practices, especially in developed nations. It is increasingly being used to guide nutritional strategies and training outcomes for a number of disorders. While wellness genomics is used to assist persons to take appropriate health decisions that promotes their wellness and help in maintenance of better health. It typically includes various genotypic and clinical information.
According to MRAResearch’s new survey, global Predictive Genetic Testing And Consumer & Wellness Genomics market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Predictive Genetic Testing And Consumer & Wellness Genomics market research.
Key companies engaged in the Predictive Genetic Testing And Consumer & Wellness Genomics industry include Illumina, BGI, Genesis Genetics, Myriad Genetics, 23andMe, Inc, Color Genomics Inc, Pathway Genomics and ARUP Laboratories, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Predictive Genetic Testing And Consumer & Wellness Genomics were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Predictive Genetic Testing And Consumer & Wellness Genomics market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Predictive Genetic Testing And Consumer & Wellness Genomics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Illumina
BGI
Genesis Genetics
Myriad Genetics
23andMe, Inc
Color Genomics Inc
Pathway Genomics
ARUP Laboratories
Segment by Type
Predictive Testing
Consumer Genomics
Wellness Genomics
Breast & Ovarian Cancer
Cardiovascular Screening
Diabetic Screening & Monitoring
Colon Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Predictive Genetic Testing And Consumer & Wellness Genomics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Predictive Genetic Testing And Consumer & Wellness Genomics market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Predictive Genetic Testing And Consumer & Wellness Genomics market research.
Key companies engaged in the Predictive Genetic Testing And Consumer & Wellness Genomics industry include Illumina, BGI, Genesis Genetics, Myriad Genetics, 23andMe, Inc, Color Genomics Inc, Pathway Genomics and ARUP Laboratories, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Predictive Genetic Testing And Consumer & Wellness Genomics were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Predictive Genetic Testing And Consumer & Wellness Genomics market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Predictive Genetic Testing And Consumer & Wellness Genomics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Illumina
BGI
Genesis Genetics
Myriad Genetics
23andMe, Inc
Color Genomics Inc
Pathway Genomics
ARUP Laboratories
Segment by Type
Predictive Testing
Consumer Genomics
Wellness Genomics
Segment by Application
Breast & Ovarian Cancer
Cardiovascular Screening
Diabetic Screening & Monitoring
Colon Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Predictive Genetic Testing And Consumer & Wellness Genomics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source